Delivery Order SPE2DB22D2206-SPE2DB25FFW10

Award Date 2/27/25
Potential Completion Date 3/20/25
Potential Value $65K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) was issued by the Defense Logistics Agency (DLA), a component of the Department of Defense. The $10,269.78 firm-fixed-price delivery order is for the supply of SAMSCA 15 MG TABLET 10S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of SAMSCA 15 MG TABLET 10S. The contract is a Firm Fixed Price Delivery Order valued at $10,261.68, with a period of performance through March 24, 2023. The contract was not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
This federal contract award, valued at $10,623.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of SAMSCA 15 MG TABLET 10S, a medical product, with a performance period ending on March 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SAMSCA 15 MG tablets. The delivery order, valued at $10,261.68, is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, worth up to $999,999,999 and expiring in November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The $10,269.78 firm fixed price delivery order is for the supply of Samsca 15 mg tablets to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565210752 - SAMSCA 15 MG TABLET 10S, a specialty medication, with a ceiling value of $10,269.78. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of August 7, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award, with award ID SPE2DB22D2206|SPE2DB25FFE86, is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $75,962.76, is for the supply of SAMSCA 30 MG TABLET 10S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 12, 2025. It is not designated as a set-aside contract....
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMJRN, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,623.60 firm fixed-price delivery order is for the supply of SAMSCA 15 MG TABLET 10S, a medical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as...
This federal contract award, valued at $41,079.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of 4564288485 - SAMSCA 15 MG TABLET 10S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of May 6, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a major supplier of pharmaceutical products and medical supplies to the...
This federal contract award to AmerisourceBergen Drug Corp is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains to support...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFW10
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of SAMSCA 15 MG TABLET 10S, a specialty medication. The firm-fixed-price delivery order, valued at $64,540.38, has a completion date of March 20, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated as a set-aside.

Generated 6/1/25, 2:52 AM